Your browser is no longer supported. Please, upgrade your browser.
Settings
SNY Sanofi daily Stock Chart
SNY [NASD]
Sanofi
Index- P/E26.78 EPS (ttm)1.59 Insider Own16.40% Shs Outstand2.48B Perf Week1.33%
Market Cap105.74B Forward P/E12.02 EPS next Y3.54 Insider Trans0.00% Shs Float2.23B Perf Month1.31%
Income3.99B PEG3.62 EPS next Q0.98 Inst Own7.60% Short Float0.12% Perf Quarter0.71%
Sales40.83B P/S2.59 EPS this Y15.50% Inst Trans-3.42% Short Ratio1.68 Perf Half Y4.29%
Book/sh25.09 P/B1.70 EPS next Y8.25% ROA- Target Price52.00 Perf Year-1.53%
Cash/sh3.02 P/C14.12 EPS next 5Y7.40% ROE- 52W Range40.00 - 45.62 Perf YTD-1.91%
Dividend1.74 P/FCF- EPS past 5Y4.80% ROI5.00% 52W High-6.66% Beta0.55
Dividend %4.09% Quick Ratio0.90 Sales past 5Y2.70% Gross Margin68.60% 52W Low6.45% ATR0.67
Employees104226 Current Ratio1.30 Sales Q/Q6.50% Oper. Margin- RSI (14)53.66 Volatility0.93% 1.23%
OptionableYes Debt/Eq0.47 EPS Q/Q-40.80% Profit Margin- Rel Volume0.46 Prev Close42.57
ShortableYes LT Debt/Eq0.39 EarningsJul 29 BMO Payout- Avg Volume1.56M Price42.58
Recom1.50 SMA201.68% SMA500.26% SMA200-0.71% Volume713,347 Change0.02%
Aug-14-19Upgrade UBS Neutral → Buy
Dec-11-18Upgrade Jefferies Hold → Buy
Nov-01-18Upgrade Barclays Underweight → Equal Weight
Oct-09-18Initiated Guggenheim Neutral
Sep-10-18Upgrade BofA/Merrill Neutral → Buy
Aug-10-18Upgrade Citigroup Neutral → Buy
Mar-23-18Upgrade Liberum Hold → Buy
Jan-23-18Downgrade Barclays Equal Weight → Underweight
Dec-06-17Downgrade BofA/Merrill Buy → Neutral
Dec-01-17Downgrade Morgan Stanley Overweight → Underweight
Nov-15-17Upgrade Barclays Underweight → Equal Weight
Aug-30-17Upgrade HSBC Securities Reduce → Hold
May-11-17Downgrade Berenberg Buy → Hold
Apr-07-17Downgrade HSBC Securities Hold → Reduce
Apr-06-17Initiated Argus Buy $50
Mar-09-17Initiated Liberum Hold
Nov-07-16Initiated Goldman Neutral
Sep-23-16Initiated Piper Jaffray Neutral
Sep-15-16Resumed JP Morgan Underweight
Sep-13-16Upgrade Exane BNP Paribas Underperform → Neutral
Aug-22-19 10:20AM  Pfizer's Xtandi Label Expansion Filing Gets Priority Review Zacks
09:10AM  Is Sanofi (SNY) a Great Value Stock Right Now? Zacks
Aug-21-19 06:00AM  Three Value Stocks for Global Gains MoneyShow
Aug-20-19 05:35PM  Biotech Stock On The Radar: Medicines Company, A Cardiovascular Pure Play With A Potential Blockbuster Benzinga
05:14PM  Inovio Ends Enrollment in Anal Dysplasia Study on VGX-3100 Zacks
Aug-15-19 08:28AM  Regeneron Gets FDA Nod for Eylea Injection Prefilled Syringe Zacks
Aug-14-19 10:00AM  Should Value Investors Consider Sanofi (SNY) Stock Now? Zacks
02:54AM  Does Sanofi's (EPA:SAN) CEO Pay Matter? Simply Wall St.
Aug-12-19 09:30AM  J&J's Tuberculosis Drug Gets FDA Nod for Adolescent Patients Zacks
02:26AM  No-deal Brexit could deepen Europe's shortage of medicines - experts Reuters
Aug-09-19 11:16AM  Inovio (INO) Q2 Earnings & Revenues Fall Shy of Estimates Zacks
09:50AM  Pharma Stock Roundup: AGN, NVO Earnings, EU Nod to SNY & ABBV Drugs for New Patients Zacks
Aug-08-19 01:40PM  MyoKardia, Inc. (MYOK) Q2 2019 Earnings Call Transcript Motley Fool
Aug-07-19 03:26PM  3 Dividend Stocks That Pay You More Than Pepsi Does Motley Fool
08:13AM  Alnylam's (ALNY) Q2 Earnings and Revenues Miss Estimates Zacks
Aug-06-19 03:00PM  Regeneron Pharmaceuticals Reports Marked Improvement in Q2 Motley Fool
01:09PM  Regeneron (REGN) Q2 Earnings Top Estimates, Eylea Sales Solid Zacks
10:45AM  BioMarin's Roller Coaster Continues Motley Fool
09:30AM  SNY vs. PFE: Which Stock Is the Better Value Option? Zacks
09:10AM  Are Investors Undervaluing Sanofi (SNY) Right Now? Zacks
08:24AM  Regeneron stock up 2.2% after earnings beat MarketWatch
07:22AM  The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering Benzinga
01:40AM  UPDATE 1-EU approves Sanofi, Regeneron's Dupixent for adolescent eczema cases Reuters
01:15AM  EU regulators approve Sanofi, Regeneron's Dupixent for adolescent cases Reuters
Aug-05-19 05:59PM  Sanofi (SNY) Q2 2019 Earnings Call Transcript Motley Fool
Aug-02-19 10:52AM  Emergent (EBS) Earnings Miss in Q2, Revenues Beat Estimates Zacks
10:52AM  BioMarin (BMRN) Shares Down on Q1 Earnings & Sales Miss Zacks
09:54AM  Pharma Stock Roundup: PFE, MRK, LLY Q2 Earnings, Upjohn-MYL Merger Zacks
Jul-30-19 09:49AM  Company News For Jul 30, 2019 Zacks
Jul-29-19 12:14PM  Here's Why Lexicon Pharmaceuticals Is Collapsing Today Motley Fool
10:41AM  Companies to Watch: mixed quarter at Sanofi, Starbucks downgraded, concerns for PayPal Yahoo Finance
10:38AM  Sanofi (SNY) Q2 Earnings Top, Dupixent Shines, EPS View Up Zacks
10:17AM  Companies to Watch: mixed quarter at Sanofi, Starbucks downgraded, concerns for PayPal Yahoo Finance Video
09:37AM  Sanofi Trades Higher On Q2 Earnings Beat Benzinga
08:53AM  Lexicon's stock loses more than half its value after Sanofi's notice to end alliance MarketWatch
08:00AM  Sanofi delivered solid growth in Q2 2019 PR Newswire
04:46AM  UPDATE 2-Europe stocks inch higher on UK merger action Reuters
02:18AM  UPDATE 1-Sanofi raises outlook after strong Q2 numbers Reuters
02:16AM  Sanofi raises outlook after strong second quarter Reuters
Jul-28-19 06:02PM  Sanofi's Earnings: A Preview Benzinga
Jul-27-19 05:05AM  Sanofi ends partnership with Lexicon to develop add-on pill for diabetes Reuters
Jul-26-19 05:58PM  UPDATE 1-Sanofi ends partnership with Lexicon to develop add-on pill for diabetes Reuters
05:05PM  Sanofi ends partnership with Lexicon to develop diabetes drug Reuters
Jul-25-19 06:52PM  Buy Merck & Co (MRK) Stock Ahead of Q2 Earnings Report? Zacks
10:26AM  AstraZeneca (AZN) Q2 Earnings Top, '19 Product Sales View Up Zacks
Jul-24-19 01:54PM  What to Expect from Sanofi's (SNY) Q2 Earnings (Revised) Zacks
12:13PM  What to Expect from Sanofi's (SNY) Q2 Earnings Zacks
09:44AM  Large-Cap Pharmaceuticals Industry Near-Term Outlook Bright Zacks
Jul-23-19 08:00AM  Opiant Pharmaceuticals Expands Partnership with Sanofi, Signs Agreement for Manufacturing OPNT004 for Treatment of Acute Cannabinoid Overdose GlobeNewswire
07:26AM  The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation Benzinga
01:15AM  Sanofi signs U.S. rights deal with Roche for flu treatment Tamiflu Reuters
Jul-19-19 09:40AM  How Does Sanofi (EPA:SAN) Fare As A Dividend Stock? Simply Wall St.
Jul-18-19 10:10AM  New Strong Buy Stocks for July 18th Zacks
Jul-17-19 11:20AM  Inovio (INO) Ends Some Early-Stage R&D Programs, Cuts Jobs Zacks
10:24AM  Merck's Antibiotic Recarbrio Gets FDA Nod for Infections Zacks
Jul-15-19 05:43PM  AstraZeneca's Farxiga Gets CRL from FDA for Type I Diabetes Zacks
07:00AM  AI Drug Hunters Could Give Big Pharma a Run for Its Money Bloomberg
Jul-12-19 09:47AM  Aimmune Down on Negative ICER Review on Allergy Candidate Zacks
09:30AM  SNY or PFE: Which Is the Better Value Stock Right Now? Zacks
09:10AM  Are Investors Undervaluing Sanofi (SNY) Right Now? Zacks
08:36AM  Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY Zacks
Jul-11-19 11:16AM  FDA Accepts Sanofi's BLA for Myeloma Candidate to Review Zacks
Jul-10-19 11:24AM  Court Ruling Topples Trump Order, No Price Display in TV Ads Zacks
07:17AM  The Daily Biotech Pulse: Jazz Buys Tumor Drug Program, Sanofi's BLA For Multiple Myeloma Drug Accepted, Positive Results For ViiV Benzinga
Jul-09-19 10:07AM  How this Peninsula biotech plans to turn a $100 million round into 'next generation' of cancer drugs American City Business Journals
Jul-05-19 09:32AM  Pharma Stock Roundup: PFE's Regulatory/Pipeline Updates, CHMP Nod for Several Drugs Zacks
Jul-04-19 10:26AM  Glaxo's Dovato Wins EU Nod, RA Candidate Enters Phase III Zacks
Jul-03-19 01:54PM  Roche's Flu Medicine Xofluza Meets Goal in Study on Kids Zacks
01:40PM  5 Dividend Stocks to Buy From Across the Globe InvestorPlace
11:49AM  Euro-Area's Biggest Companies Index Enters Bull Market on Trade Bloomberg
10:22AM  Amarin (AMRN) Issues Update on Q2 Sales, Raises '19 Guidance Zacks
Jul-02-19 05:27PM  Livongo Leading Digital Health Charge Back Into Public Market GuruFocus.com
04:56PM  Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis Zacks
11:31AM  CORRECTED-Pfizer, Sanofi, to boost South African Biovac's vaccine output Reuters
09:31AM  Regeneron/Sanofi's Libtayo Gets EU Approval for Skin Cancer Zacks
09:09AM  Pfizer, Sanofi, to boost South African Biovac's vaccine output Reuters
Jul-01-19 11:00PM  Patent panic gives green light to mega pharma deals Financial Times
11:00AM  Regeneron/Sanofi's Dupixent Gets Positive CHMP Recommendation Zacks
Jun-28-19 10:10AM  Novavax (NVAX) Seeks Accelerated Approval Pathway for NanoFlu Zacks
Jun-27-19 10:30AM  FDA Accepts Sanofi's BLA for Meningitis Vaccine to Review Zacks
07:39AM  Regeneron & Sanofi Get FDA Nod for Dupixent Label Expansion Zacks
07:26AM  The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO Benzinga
Jun-26-19 01:46PM  UPDATE 2-FDA approves expanded label for Regeneron/Sanofi's Dupixent Reuters
01:34PM  FDA approves expanded label for Regeneron/Sanofi's Dupixent Reuters
01:30PM  FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis PR Newswire
Jun-25-19 11:39AM  Acer Therapeutics stock plummets 80 percent on FDA rejection American City Business Journals
09:24AM  Regeneron Pharma Turnaround Gains Steam Investopedia
Jun-22-19 09:33AM  This would be the worst-case scenario for health stocks, according to UBS MarketWatch
Jun-21-19 04:15PM  Regeneron And Sanofi Tried To Outperform Themselves And Couldn't Investor's Business Daily
10:30AM  Sanofi/Regeneron's Asthma Candidate Meets Goal in Study Zacks
09:07AM  Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod Zacks
07:18AM  The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy Benzinga
Jun-20-19 09:47AM  The Zacks Analyst Blog Highlights: Alphabet, Amazon, Apple, Sanofi and Walgreens Zacks
Jun-19-19 08:09PM  Heres What Hedge Funds Think About Sanofi (SNY) Insider Monkey
10:52AM  Sanofi plans 466 job cuts as part of R&D reshuffle Reuters
09:07AM  Alphabet's Healthcare Push Gains Steam: Others Brace Up Zacks
Jun-18-19 10:54AM  Sanofi, Google Partner On Health Care-Focused Virtual Innovation Lab Benzinga
10:30AM  Sanofi Partners Google to Build Healthcare Innovation Lab Zacks
10:27AM  Protalix (PLX) Completes Enrollment in Fabry Disease Study Zacks
09:18AM  Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients Zacks
Sanofi provides therapeutic solutions worldwide. It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1; and Aubagio, an immunomodulatory and Lemtrada, a monoclonal antibody for multiple sclerosis. It also provides Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Eloctate and Alprolix to treat hemophilia in adults and children; and Cablivi to treat acquired thrombotic thrombocytopenic purpura in adults. In addition, it offers Libtayo for metastatic cutaneous squamous cell carcinoma; Jevtana and Taxotere taxane for cancers; Eloxatin for colon cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, for hematologic malignancies; and Zaltrap, for metastatic colorectal cancer. Further, it provides Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl sulfonylurea; Adlyxin/Lyxumia, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug for atrial fibrillation. Additionally, it offers Plavix for atherothrombotic conditions; Lovenox for the prophylaxis, venous thromboembolism, and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; Allegra for seasonal allergic rhinitis and uncomplicated hives; and Depakine for epilepsy. It also provides generic products; and products for allergy, cough, cold, pain, nutrition, digestion, pediatrics, influenza, meningitis, travel, and endemic vaccines; and adult and adolescent boosters. The company has an alliance with Verily Life Sciences LLC. Sanofi was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanofi10% OwnerJul 22Buy16.0093,7501,500,000558,035Jul 23 11:39 AM
Sanofi10% OwnerMar 08Sale412.17131,11554,041,31620,723,717Mar 12 08:19 PM
Sanofi10% OwnerSep 06Sale406.68104,55242,519,24923,654,384Sep 10 05:01 PM